Table 1.

Sequence of primers used in RT-PCR assays

GeneSense primerAntisense primer
hC/EBPε CAGACAGGAAGGCGCTGGG CGGCAGTGGCCAAAGGGGCCTT 
mC/EBPε GCTACAATCCCCTGCAGTACC CACAAGGGCAAGAAGGCA 
CD14 CCCGACCCTCCAAGTTTT ACCTGCTTCAGCCCAGTG 
Mona TCTGCAGCATTTCCACCA GGAATCCCAGCTCGTCCT  
Fcγ RI TCGGTGGGGAAGTGGTTA CTGGCCTCTGGGATGCTA 
PAI-2 TTGAGGACGCATCCACTG GCCTTGCCCTTGTTGAAG 
IRK1 CTTGCCTTCGTGCTCTCC TTGGGCACTCGTCTGTCA  
VLA5 (α) GCAGCTGCATTTCCGAGT CCACAACGGGACACCATT  
VLA5 (β) AGCACAACCCCAGCAAAG GATCCACAAACCGCAACC 
IL-12p40 TCATGGCTGGTGCAAAGA AGGGTCTCCTCGGCAGTT 
IL-12p35 AGTTCCAGGCCATCAACG AAGGCGTGAAGCAGGATG 
IL-18 CAGTGAACCCCAGACCAGAC TCAGGTGGATCCATTTCCTC 
IL-15 CTGAGGCTGGCATTCATGT GCAATTCCAGGAGAAAGCAG 
IL-6 GTGACAACCACGGCCTTC TTCTGCAAGTGCATCATCG 
IL-10 TTGGGTTGCCAAGCCTTA ACCTGCTCCACTGCCTTG 
MCP-3 TTCTGTGCCTGCTGCTCA GCTTCAGCGCAGACTTCC 
M-CSF GCCAGACCCTCGAGTCAA CGTGGAGGGGGAAAACTT 
c-fms CCGGGCTCTCAGTCTCAA CATCTGCATGGACCGTGA 
MCP-1 AGCCAATCAGCCATCTGC CTCTATGGCCTGCGGTGT 
c-maf AGGCGGACCCTGAAAAAC TTTTCTCGGAAGCCGTTG 
IL-1RA CCCTGCCACAAACACACA ATGTGATGCCCTGGTGGT 
NOS ACGCTGGCTACCAGATGC GGGATGCTCCATGGTCAC 
TNF-α GTGCTCCTCACCCACACC GGGCAGATTGACCTCAGC 
IP-10 ACGGGCCAGTGAGAATGA TGTGTGCGTGGCTTCACT 
ICSBP ACCAAGAGGAGCCCATCC TTCAAGGCAGGTGGTGGT 
MR CGGCATGGGTTTTACTGC CACCGAAACGTCCCTTTG  
SR type 1 ATTGGCTTCCCTGGAGGT CACTGGCCTTGGTGGAAG  
SR type 2 GGGAGTGTAGGCGGATCA GCATGGCATGACACAGGA 
18S AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA 
GeneSense primerAntisense primer
hC/EBPε CAGACAGGAAGGCGCTGGG CGGCAGTGGCCAAAGGGGCCTT 
mC/EBPε GCTACAATCCCCTGCAGTACC CACAAGGGCAAGAAGGCA 
CD14 CCCGACCCTCCAAGTTTT ACCTGCTTCAGCCCAGTG 
Mona TCTGCAGCATTTCCACCA GGAATCCCAGCTCGTCCT  
Fcγ RI TCGGTGGGGAAGTGGTTA CTGGCCTCTGGGATGCTA 
PAI-2 TTGAGGACGCATCCACTG GCCTTGCCCTTGTTGAAG 
IRK1 CTTGCCTTCGTGCTCTCC TTGGGCACTCGTCTGTCA  
VLA5 (α) GCAGCTGCATTTCCGAGT CCACAACGGGACACCATT  
VLA5 (β) AGCACAACCCCAGCAAAG GATCCACAAACCGCAACC 
IL-12p40 TCATGGCTGGTGCAAAGA AGGGTCTCCTCGGCAGTT 
IL-12p35 AGTTCCAGGCCATCAACG AAGGCGTGAAGCAGGATG 
IL-18 CAGTGAACCCCAGACCAGAC TCAGGTGGATCCATTTCCTC 
IL-15 CTGAGGCTGGCATTCATGT GCAATTCCAGGAGAAAGCAG 
IL-6 GTGACAACCACGGCCTTC TTCTGCAAGTGCATCATCG 
IL-10 TTGGGTTGCCAAGCCTTA ACCTGCTCCACTGCCTTG 
MCP-3 TTCTGTGCCTGCTGCTCA GCTTCAGCGCAGACTTCC 
M-CSF GCCAGACCCTCGAGTCAA CGTGGAGGGGGAAAACTT 
c-fms CCGGGCTCTCAGTCTCAA CATCTGCATGGACCGTGA 
MCP-1 AGCCAATCAGCCATCTGC CTCTATGGCCTGCGGTGT 
c-maf AGGCGGACCCTGAAAAAC TTTTCTCGGAAGCCGTTG 
IL-1RA CCCTGCCACAAACACACA ATGTGATGCCCTGGTGGT 
NOS ACGCTGGCTACCAGATGC GGGATGCTCCATGGTCAC 
TNF-α GTGCTCCTCACCCACACC GGGCAGATTGACCTCAGC 
IP-10 ACGGGCCAGTGAGAATGA TGTGTGCGTGGCTTCACT 
ICSBP ACCAAGAGGAGCCCATCC TTCAAGGCAGGTGGTGGT 
MR CGGCATGGGTTTTACTGC CACCGAAACGTCCCTTTG  
SR type 1 ATTGGCTTCCCTGGAGGT CACTGGCCTTGGTGGAAG  
SR type 2 GGGAGTGTAGGCGGATCA GCATGGCATGACACAGGA 
18S AAACGGCTACCACATCCAAG CCTCCAATGGATCCTCGTTA 

Mona indicates monocytic adaptor; FcγRI, Fcγ receptor type I; PAI-2, plasminogen activator inhibitor type-2; IRK1, inwardly rectifying potassium channel; VLA5, fibronectin receptor; c-fms, macrophage colony-stimulating factor receptor; IL-1RA, IL-1 receptor antagonist; NOS, nitric oxide synthase; TNF-α, tumor necrosis factor-α; IP-10, IFN-γ inducible protein 10; ICSBP, IFN consensus sequence-binding protein; MR, mannose receptor; SR, scavenger receptor.

Close Modal

or Create an Account

Close Modal
Close Modal